Belpointe Asset Management’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,066
| Closed | -$2.24K | – | 1613 |
|
|
2023
Q1 | $2.24K | Hold |
1,066
| – | – | ﹤0.01% | 3281 |
|
|
2022
Q4 | $1.21K | Buy |
+1,066
| New | +$1.21K | ﹤0.01% | 3400 |
|
|
2019
Q3 | – | Sell |
-29,228
| Closed | -$121K | – | 683 |
|
|
2019
Q2 | $121K | Buy |
29,228
+2,230
| +8% | +$9.23K | 0.02% | 539 |
|
|
2019
Q1 | $138K | Buy |
+26,998
| New | +$138K | 0.03% | 376 |
|
|
2018
Q4 | – | Sell |
-31,129
| Closed | -$187K | – | 547 |
|
|
2018
Q3 | $187K | Sell |
31,129
-12,427
| -29% | -$74.7K | 0.03% | 468 |
|
|
2018
Q2 | $277K | Buy |
+43,556
| New | +$277K | 0.08% | 276 |
|